Novartis
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novartis and other ETFs, options, and stocks.About NVS
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate.
NVS Key Statistics
NVS News
Novartis NVS presented encouraging results from a pre-specified interim analysis of the phase III APPLAUSE-IgAN study of Fabhalta (iptacopan). Fabhalta, an ora...
Novartis (NVS) presented results from a pre-specified interim analysis of the Phase 3 APPLAUSE-IgAN study of Fabhalta, an investigational Factor B inhibitor of...
Novartis NVS entered into an exclusive strategic license agreement with a clinical-stage biotechnology company, Arvinas, Inc. ARVN, for the worldwide developmen...
Analyst ratings
52%
of 25 ratingsMore NVS News
The Management Board and Supervisory Board of MorphoSys AG (MOR) issued a joint reasoned statement on the voluntary public takeover offer by Novartis BidCo AG,...
If you buy and hold a stock for many years, you'd hope to be making a profit. Better yet, you'd like to see the share price move up more than the market average...
Biotech stocks heated up Thursday, driven by a spate of deals, as Novartis (NVS) scooped up a licensing pact with Arvinas Therapeutics (ARVN) and Janux Therapeu...
Novartis offers € 68.00 per share in cash, representing a total equity value of € 2.7 billion Shareholders benefit from attractive premium of 94% and 142% on t...
(Adds shares in paragraph 2, analyst comment in paragraph 6, details in paragraph 7) April 11 (Reuters) - Swiss drugmaker Novartis AG has entered into a licens...
Arvinas (ARVN) announced it has entered into an exclusive strategic license agreement with Novartis (NVS) for the worldwide development and commercialization of...